Results 1 to 10 of about 7,245,224 (256)

Multi-label classification for multi-drug resistance prediction of Escherichia coli

open access: yesComputational and Structural Biotechnology Journal, 2022
Antimicrobial resistance (AMR) is a global health and development threat. In particular, multi-drug resistance (MDR) is increasingly common in pathogenic bacteria.
Yunxiao Ren   +7 more
doaj   +3 more sources

Correlation Analysis Between Multi-Drug Resistance Phenotype and Virulence Factor Expression of Clinical Pseudomonas aeruginosa [PDF]

open access: yesCurrent Issues in Molecular Biology
Pseudomonas aeruginosa (PA), as a common pathogen of nosocomial infections, has been experiencing an increasing rate of drug resistance with the widespread use and abuse of antimicrobial drugs.
Wenli Xu   +11 more
doaj   +2 more sources

Glutathione‐Sensitive Photosensitizer–Drug Conjugates Target the Mitochondria to Overcome Multi‐Drug Resistance in Cancer [PDF]

open access: yesAdvanced Science
Multi‐drug resistance (MDR) is a major cause of cancer therapy failure. Photodynamic therapy (PDT) is a promising modality that can circumvent MDR and synergize with chemotherapies, based on the generation of reactive oxygen species (ROS) by ...
Weiguo Song   +13 more
doaj   +2 more sources

Modeling spatial evolution of multi-drug resistance under drug environmental gradients. [PDF]

open access: yesPLoS Computational Biology
Multi-drug combinations to treat bacterial populations are at the forefront of approaches for infection control and prevention of antibiotic resistance.
Tomas Ferreira Amaro Freire   +3 more
doaj   +2 more sources

Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling

open access: yesFrontiers in Oncology, 2021
Ovarian cancer is the most lethal gynaecologic tumor, with which multi-drug resistance as the major therapeutic hindrance. Heat shock protein 90 (Hsp90) has been involved in cancer malignant behaviors.
Lan Yin   +8 more
doaj   +1 more source

The impact of COVID-19 on the tuberculosis control activities in Addis Ababa

open access: yesThe Pan African Medical Journal, 2021
The first COVID-19 case was reported in Ethiopia on 13th March 2020 and series of announcements of set of measures, proclamation and directives have been enacted to fight the coronavirus pandemic.
Negussie Wodajo Beyene   +3 more
doaj   +1 more source

Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018

open access: yesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2021
Background: In 2019, the World Health Organization released guidelines reflecting major changes in multidrug-resistant tuberculosis (MDR-TB) management—prioritizing fluoroquinolones, bedaquiline, and linezolid (LZD) while de-emphasizing previously ...
Ashley McDowell   +8 more
doaj   +1 more source

Optimal drug synergy in antimicrobial treatments. [PDF]

open access: yesPLoS Computational Biology, 2010
The rapid proliferation of antibiotic-resistant pathogens has spurred the use of drug combinations to maintain clinical efficacy and combat the evolution of resistance.
Joseph Peter Torella   +2 more
doaj   +1 more source

Drug Resistance Reversal Potential of Nanoparticles/Nanocomposites via Antibiotic’s Potentiation in Multi Drug Resistant P. aeruginosa

open access: yesNanomaterials, 2021
Bacteria employ numerous resistance mechanisms against structurally distinct drugs by the process of multidrug resistance. A study was planned to discover the antibacterial potential of a graphene oxide nanosheet (GO), a graphene oxide–zinc oxide ...
Pratima Pandey   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy